ASH 2009 Highlights
Saturday, January 23, 2010
7:30 am – 4:00 pm
The Joseph B. Martin Conference Center at Harvard Medical School
Boston, MA
Offered by Dana-Farber/Brigham and Women's Cancer Center, the Leukemia and Lymphoma Society, and Harvard Medical School Department of Continuing Education
Quicklinks
Course Objectives | Agenda | Faculty
Registration Information
Course Objectives
This course is designed to provide hematologists, medical oncologists, nurse practitioners, and other interested clinicians with the most up-to-date information on recent advances in diagnosing and treating hematologic malignancies. Attendees will learn about medical advances presented at the 2009 Annual Meeting of the American Society of Hematology for acute leukemia, lymphoma, chronic lymphocytic leukemia, stem cell transplantation, multiple myeloma, myeloproliferative diseases, and coagulation. In addition, faculty will discuss challenging cases involving MDS, multiple myeloma, and follicular lymphoma.
About the Center for Hematologic Oncology at Dana-Farber/Brigham and Women's Cancer Center
We offer advanced, specialized care for patients with all types of hematologic malignancies, including leukemia and similar bone marrow disorders, lymphoma, multiple myeloma, Waldenstrom's macroglobulinemia, and other related blood disorders.
Together with our partner in adult care, Brigham and Women's Hospital, we are national leaders in stem cell transplantation, performing more than 500 transplants each year.
Our team of specialists is actively involved in basic and clinical research that advances the understanding and treatment of hematologic malignancies. Patients have access to many clinical trials that explore new therapies for those with hematologic disorders.
Agenda
7:30 am
Registration and Continental Breakfast
8:00 am
Welcome and Introduction
Robert J. Soiffer, MD
8:15 am
Acute Leukemia
Richard M. Stone, MD
9:00 am
Lymphoma
Ann S. LaCasce MD
9:45 am
MDS and Myeloproliferative Disorders
Daniel J. DeAngelo, MD
10:30 am
Break
10:45 am
Coagulation
Jeffery I. Zwicker, MD
11:30 am
Multiple Myeloma
Jacob Laubach, MD, MPP
12:15 pm
Lunch
1:15 pm
Chronic Lymphocytic Leukemia
Jennifer R. Brown, MD
2:00 pm
Stem Cell Transplantation
Karen K. Ballen, MD
2:45 pm
Case Discussions: MDS, Multiple Myeloma, Follicular Lymphoma
Moderator: David E. Avigan, MD
4:00 pm
Evaluation and Adjourn
Faculty
Robert J. Soiffer, MD, Course Director
Clinical Director, Hematologic Malignancies
Co-Chief, Stem Cell/Bone Marrow Transplantation Program
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine
Harvard Medical School
David E. Avigan, MD
Director, Hematologic Malignancies/Bone Marrow Transplant
Beth Israel Deaconess Medical Center;
Associate Professor of Medicine
Harvard Medical School
Karen K. Ballen, MD
Director, Center for Leukemia
Massachusetts General Hospital Cancer Center;
Associate Professor of Medicine
Harvard Medical School
Jennifer R. Brown, MD
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine
Harvard Medical School
Daniel J. DeAngelo, MD
Clinical Director, Adult Leukemia
Dana-Farber/Brigham and Women's Cancer Center;
Assistant Professor of Medicine
Harvard Medical School
Ann S. LaCasce MD
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine
Harvard Medical School
Jacob Laubach, MD, MPP
Dana-Farber/Brigham and Women's Cancer Center;
Instructor in Medicine
Harvard Medical School
Richard M. Stone, MD
Program Director, Adult Leukemia
Dana-Farber/Brigham and Women's Cancer Center;
Professor of Medicine
Harvard Medical School
Jeffrey I. Zwicker, MD
Beth Israel Deaconess Medical Center;
Instructor in Medicine
Harvard Medical School
Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.
Harvard Medical School designates this educational activity for a maximum of 7.5 AMA PRA Category 1 credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
For nurses, up to 7.5 hours of Continuing Education Credit will be awarded by The Leukemia & Lymphoma Society for this lecture. Nurses must provide their RN license number in the order to receive credit. Provider approved by the California Board of Registered Nursing Provider number CEP5832.
Registration Information
Registration Fee: $60 (non-refundable); includes continental breakfast and lunch.
To register, call (800) 553-3787 or click here
If you have food allergies, or if you require accommodations such as an ASL interpreter, materials in alternative format or wheelchair access, please email kwooten@partners.org or call (800) 553-3787.
